Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-01

Clinical Trial Update: Initial Study of Rituximab to Treat Primary Biliary Cirrhosis [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating rituximab for primary biliary cirrhosis, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rituximab (rituximab)

Snippet

Sponsor: University of California, Davis | Conditions: Primary Biliary Cirrhosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-06-01